144 related articles for article (PubMed ID: 25312098)
1. Growth impairment after TBI of leukemia survivors children: a model- based investigation.
Galletto C; Gliozzi A; Nucera D; Bertorello N; Biasin E; Corrias A; Chiabotto P; Fagioli F; Guiot C
Theor Biol Med Model; 2014 Oct; 11():44. PubMed ID: 25312098
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-Up Study (LEA).
Isfan F; Kanold J; Merlin E; Contet A; Sirvent N; Rochette E; Poiree M; Terral D; Carla-Malpuech H; Reynaud R; Pereira B; Chastagner P; Simeoni MC; Auquier P; Michel G; Deméocq F
Bone Marrow Transplant; 2012 May; 47(5):684-93. PubMed ID: 21725370
[TBL] [Abstract][Full Text] [Related]
3. The impact of total body irradiation-based regimens on outcomes in children and young adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
Friend BD; Bailey-Olson M; Melton A; Shimano KA; Kharbanda S; Higham C; Winestone LE; Huang J; Stieglitz E; Dvorak CC
Pediatr Blood Cancer; 2020 Feb; 67(2):e28079. PubMed ID: 31724815
[TBL] [Abstract][Full Text] [Related]
4. The paradigm of total body irradiation in acute lymphoblastic leukaemia: Therapeutic effectiveness versus the challenges of toxicity.
Echecopar C; Del Val Rey I; Galán-Gómez V; González-Pérez C; Mozo Del Castillo Y; González Martínez B; Pérez-Martínez A
An Pediatr (Engl Ed); 2024 Apr; 100(4):259-267. PubMed ID: 38548564
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis.
Friedman DN; Hilden P; Moskowitz CS; Suzuki M; Boulad F; Kernan NA; Wolden SL; Oeffinger KC; Sklar CA
Biol Blood Marrow Transplant; 2017 Mar; 23(3):475-482. PubMed ID: 28040534
[TBL] [Abstract][Full Text] [Related]
6. Influence of Total Body Irradiation Dose Rate on Idiopathic Pneumonia Syndrome in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Gao RW; Weisdorf DJ; DeFor TE; Ehler E; Dusenbery KE
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):180-189. PubMed ID: 30205123
[TBL] [Abstract][Full Text] [Related]
7. Safety and cost-effectiveness of outpatient total body irradiation in pediatric patients undergoing stem cell transplantation.
Farah RA; Aquino VM; Munoz LL; Sandler ES
J Pediatr Hematol Oncol; 1998; 20(4):319-21. PubMed ID: 9703004
[TBL] [Abstract][Full Text] [Related]
8. Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence.
Vatanen A; Wilhelmsson M; Borgström B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K
Eur J Endocrinol; 2014 Feb; 170(2):211-8. PubMed ID: 24179099
[TBL] [Abstract][Full Text] [Related]
9. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.
Michel G; Socié G; Gebhard F; Bernaudin F; Thuret I; Vannier JP; Demeocq F; Leverger G; Pico JL; Rubie H; Mechinaud F; Reiffers J; Gratecos N; Troussard X; Jouet JP; Simonin G; Gluckman E; Maraninchi D
J Clin Oncol; 1997 Jun; 15(6):2238-46. PubMed ID: 9196136
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood.
Bakker B; Oostdijk W; Geskus RB; Stokvis-Brantsma WH; Vossen JM; Wit JM
Clin Endocrinol (Oxf); 2007 Oct; 67(4):589-97. PubMed ID: 17590170
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation.
Ishida H; Kato M; Kudo K; Taga T; Tomizawa D; Miyamura T; Goto H; Inagaki J; Koh K; Terui K; Ogawa A; Kawano Y; Inoue M; Sawada A; Kato K; Atsuta Y; Yamashita T; Adachi S
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2141-2147. PubMed ID: 26271192
[TBL] [Abstract][Full Text] [Related]
12. Final adult height of patients who received hematopoietic cell transplantation in childhood.
Sanders JE; Guthrie KA; Hoffmeister PA; Woolfrey AE; Carpenter PA; Appelbaum FR
Blood; 2005 Feb; 105(3):1348-54. PubMed ID: 15454481
[TBL] [Abstract][Full Text] [Related]
13. Childhood cancer survivors exposed to total body irradiation are at significant risk for slipped capital femoral epiphysis during recombinant growth hormone therapy.
Mostoufi-Moab S; Isaacoff EJ; Spiegel D; Gruccio D; Ginsberg JP; Hobbie W; Shults J; Leonard MB
Pediatr Blood Cancer; 2013 Nov; 60(11):1766-71. PubMed ID: 23818448
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of pediatric patients receiving total body irradiation before hematopoietic stem cell transplantation and post-transplant survival of >2 years.
Künkele A; Engelhard M; Hauffa BP; Mellies U; Müntjes C; Hüer C; Eggert A; Schulte JH; Kremens B
Pediatr Blood Cancer; 2013 Nov; 60(11):1792-7. PubMed ID: 23893964
[TBL] [Abstract][Full Text] [Related]
15. Outcome Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia Treated with Total Body Irradiation-Free Allogeneic Hematopoietic Stem Cell Transplantation: Comparison of Patients with and Without Central Nervous System Involvement.
Hamidieh AA; Monzavi SM; Kaboutari M; Behfar M; Esfandbod M
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2110-2117. PubMed ID: 28870778
[TBL] [Abstract][Full Text] [Related]
16. Comparative outcome of hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia following cyclophosphamide and total body irradiation or VP16 and total body irradiation conditioning regimens.
Gassas A; Sung L; Saunders EF; Doyle JJ
Bone Marrow Transplant; 2006 Dec; 38(11):739-43. PubMed ID: 17013424
[TBL] [Abstract][Full Text] [Related]
17. Comparison of chemotherapeutic agents as a myeloablative conditioning with total body irradiation for pediatric acute lymphoblastic leukemia: A study from the pediatric ALL working group of the Japan Society for Hematopoietic Cell Transplantation.
Kato M; Ishida H; Koh K; Inagaki J; Kato K; Goto H; Kaneko T; Cho Y; Hashii Y; Kurosawa H; Takita J; Hamamoto K; Inoue M; Sawada A; Suzuki R; Kato K
Pediatr Blood Cancer; 2015 Oct; 62(10):1844-50. PubMed ID: 26053959
[TBL] [Abstract][Full Text] [Related]
18. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation.
Hovi L; Saarinen-Pihkala UM; Vettenranta K; Lipsanen M; Tapanainen P
Bone Marrow Transplant; 1999 Nov; 24(10):1131-6. PubMed ID: 10578163
[TBL] [Abstract][Full Text] [Related]
19. Pubertal development and final height after autologous bone marrow transplantation for acute lymphoblastic leukemia.
Frisk P; Arvidson J; Gustafsson J; Lönnerholm G
Bone Marrow Transplant; 2004 Jan; 33(2):205-10. PubMed ID: 14628079
[TBL] [Abstract][Full Text] [Related]
20. Irradiation free conditioning regimen is associated with high relapse rate in Egyptian patients with acute lymphoblastic leukemia following allogeneic hematopoietic stem cell transplantation.
Abdelaty MM; Gawaly A; Fathy GM; Kabbash I; Taha A
J Egypt Natl Canc Inst; 2020 Jun; 32(1):28. PubMed ID: 32537680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
